Welcome to Immunology Conferences

Upcoming Immunology Conferences

Immunology Conferences 2017

Conferenceseries Destinations


Target Audience for Immunology Conferences 

Immunology Conference is to gathering people in academia and society interested in immunology to share the latest trends and important issues relevant to field or subject area. Immunology Conference brings together the global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. The Immunology events host presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology. Immunology Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. The conference will include invited speakers, oral presentations, poster session and the young scientist award. Targets, CEO’s, Directors, Scientists, Professors, Students of all Biotech & Pharma companies, Universities and colleges globally.

Benefits of Attending CME Conferences

Immunology CME conferences is your best opportunity to reach the largest assemblage of participants from the immunology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in immunology are hallmarks of this CME    conference.

Benefits of Attending CPD/CE Conferences

With members from around the world focused on learning about immunology and its advances, attending a CPD/CE accredited conference, seminar or a workshop helps the practical, academic, research and business areas of Immunology. The Conference will bring together academicians, engineers, experts and biomedical teachers/students from all over the world helps in accomplishing larger targets.

Market Value of Immunology

Global Immunology Market to reach $74.2 Billion by 2022 the complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing. Market access presents a significant hurdle for immunotherapeutic procedures, as many are high cost and do not deliver the measurements required for traditional cost-effectiveness assessments. Despite these restraining factors, The market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%.Immunology Market to 2022: From $61.5 Billion in 2015 to $74.2 Billion - Large Pipeline and Competitive Market to Drive Long-Term Market Growth. Global Immunology Market to 2022 is the large pipeline and competitive market to drive long-term market growth

In America

Global medicines market is expected to perform well in the American region and it will take up more than 33% of the market value share by the period of prediction. The global market in North America will flourish and will probably touch the approximate market value of more than US $ 60 MN by 2024 over. With stupendous performances in the US and Canada will successfully overcome a climb share of the global medicines market says the report.

In Europe

Europe is a consistent market and will climb up the revenue chart successfully. Within the forecast period. The market in Europe will ride an estimated CAGR more than 17% to an average rated of more than US $ 40 MN by the end of 2024. In Europe the markets spread across France, Germany will shape the destiny of this market. At a distance from this the countries such as Spain, United Kingdom and Italy will follow during the period of assessment.

In Asia and Middle East

However the growth of the market may be significant in emerging economies in Asia, Africa and Middle East considering high incidence and prevalence rate for infections. This market can also be segmented according various categories of infections such as hepatitis viruses, retroviruses and other infections. The market has different classes of products used such as reagents, diagnostic kits, instruments and others. In the Asia and Middle East region Japan will spearhead the market, China and India will engage in conflict to accumulate maximum market share during the projected period.